Abiopharma

News list

Director Knie Robb 🟡 adjusted position in 489.3K shares of Hoth Therapeutics, Inc. (HOTH) at $1.21 Transaction Date: Aug 27, 2025 | Filing ID: 081945

Full text

News bot Aug. 28, 2025, 10:50 p.m.
🔍 Knie Robb (Director)

Company: Hoth Therapeutics, Inc. (HOTH)

Report Date: 2025-08-27
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 800,000
- Total shares sold: 310,744
Detailed Transactions and Holdings:
- Acquired 800,000 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 858,131.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 310,744 shares of Common Stock at $1.21 per share (Direct)
  Date: 2025-08-28 | Code: F | equity_swap_involved: 0 | shares_owned_after: 547,387.00 | transaction_form_type: 4
Footnotes:
- F1: The restricted stock was issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant.